NGS Super
Funding rounds backed by NGS Super.
- Funding disclosed in full
- $123.3M
- Median round
- $61.6M
- Rounds in calculation
- 2
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Oricell Therapeutics Develops next-generation cell therapies for oncology and immunology | $110MPre-IPO | BiotechChina | |||
| Cauldron Ferm Provides continuous hyper-fermentation technology for industrial-scale bio-production | $13.3MSeries A2 | BiotechAustralia |